Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
How to prepare for the Fed's forthcoming interest rate cuts
Recommended
The sun now sets before 8 p.m. Will we ever do away with the time change?
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Next/Generation Psychedelics
Recent news which mentions Next/Generation Psychedelics
Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth
March 27, 2024
Tickers
ENVB
Tags
Psychedelics
Earnings
Benzinga
From
Benzinga
Fed Agency Grants $14M To Gilgamesh For Cardiac-Safe Ibogaine Analog Targeting Opioid Use Disorder
March 15, 2024
Tickers
NEWS
Tags
Market News
Cannabis
Next/Generation Psychedelics
From
Benzinga
Cybin's Novel Psilocybin Topline Data: 79% Remission In Major Depression Symptoms, What's Next?
December 03, 2023
Tickers
CYBN
Tags
Management
CYBN
Psychedelic/Assisted Therapies
From
Benzinga
Clearmind Medicine's Reverse Stock Split And Nasdaq Delisting Notice
November 21, 2023
Tickers
CMND
Tags
Psychedelics
Benzinga
Nasdaq Compliance
From
Benzinga
Enveric Biosciences' Revenue Drops In Q3 2023 As Next-Gen Psychedelics Advance To Clinical Trials
November 14, 2023
Tickers
ENVB
Tags
Penny Stocks
Earnings
News
From
Benzinga
Atai Life Sciences' Q3 Earnings: Near $20M Burned QoQ, Says Funding 'Sufficient' To Streamline 2026
November 14, 2023
Tickers
ATAI
CMPS
Tags
ATAI
News
Penny Stocks
From
Benzinga
Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic
September 18, 2023
Tickers
MSSTF
Tags
Benzinga
Psychedelics
Postpartum Depression
From
Benzinga
Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program
September 06, 2023
Tickers
CMND
Tags
Psychedelics
Benzinga
Psychedelic/Assisted Therapies
From
Benzinga
Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions
August 31, 2023
Tickers
CYBN
DMTTF
MSSTF
NUGL
Tags
Psychedelic/Assisted Therapies
Otsuka Pharmaceutical Co
CYBN
From
Benzinga
Boosting Next-Gen Mental Health Care: Enveric's New US Patent For Anxiety Treatment
August 28, 2023
Tickers
ENVB
Tags
News
Penny Stocks
ENVB
From
Benzinga
Psychedelics IP Protection: Cybin Nabs US Patent For Deuterated Analogs, Psilera Advances Next-Gen Library
August 16, 2023
Tickers
CYBN
Tags
Next/Generation Psychedelics
Patents
Cannabis
From
Benzinga
Enveric's Q2 2023 Financials Show Immediate Need For Budget-Slimming Toward A Clinical-Staged 2024
August 14, 2023
Tickers
ENVB
Tags
ENVB
Global
Next/Generation Psychedelics
From
Benzinga
Bright Mind Shares Surge 91% After Reporting Positive EEG Clinical Results Of Next-Gen Compound
August 08, 2023
Tickers
DRUG
Tags
Markets
Cannabis
Market News
From
Benzinga
Reunion Neuroscience Completes Take-Private Setup: Delisting & Consideration Details
August 01, 2023
Tickers
REUN
Tags
Next/Generation Psychedelics
Markets
Market News
From
Benzinga
Terran Biosciences Steps Into 4-OH-DiPT Prodrug Arena With New Patent Application
July 18, 2023
Tickers
MSSTF
REUN
Tags
REUN
Management
Legal
From
Benzinga
Reunion Neuroscience On The Brink Of Going Private With Final Court Approval
July 17, 2023
Tickers
FTHWF
MSSTF
REUN
Tags
Psychedelics
Benzinga
Psychedelic/Assisted Therapies
From
Benzinga
Pioneering Psychedelics Scientist Alexander "Sasha" Shulgin's Legacy Lives On Via New Compounds And Research
July 10, 2023
Tags
Management
Psychedelic/Assisted Therapies
Dr/ Nicholas Cozzi
From
Benzinga
This Biotech Is Entering The Clinical Stage With A Psilocin Analog Targeting Cluster Headaches
June 28, 2023
Tickers
LOBEF
Tags
Penny Stocks
News
Market News
From
Benzinga
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
June 28, 2023
Tickers
BETRF
PHRRF
Tags
Psychedelics
Benzinga
PHRRF
From
Benzinga
Cybin's FY2023 Financials, Guidance And Appointment Of Sanford R. Climan As Strategic Advisor
June 28, 2023
Tickers
CYBN
Tags
Earnings
Penny Stocks
Guidance
From
Benzinga
UK Greenlights Phase 2 Clinical Trial On Mindset Pharma's Psilocin Drug For Major Depression
June 27, 2023
Tickers
MSSTF
Tags
Psychedelics
Benzinga
psilocybin therapies
From
Benzinga
Canadian Financing: PharmAla Biotech Offers Non-Brokered Private Placement Up To $3.76M
June 13, 2023
Tickers
PMBHF
Tags
Guidance
News
Contracts
From
Benzinga
Mydecine's Prospectus Supplement Closing Under Share Subscription And Management Update
May 30, 2023
Tickers
MYCOF
Tags
Management
Benzinga
Psychedelics
From
Benzinga
This Company's Psilocybin-Based Non Hallucinogenic Compound Heads Toward Clinical Studies
May 28, 2023
Tags
News
Benzinga
Psychedelics
From
Benzinga
Promising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing Completed
May 10, 2023
Tickers
HUGE
Tags
Psychedelic/Assisted Therapies
Psychedelics
Benzinga
From
Benzinga
Delix's Non-Hallucinogenic Psychoplastogen Enters Phase 1 Trial
May 09, 2023
Tags
News
Delix Therapeutics
Psychedelics
From
Benzinga
NY Biotech Gets International IP Coverage For Growing Portfolio Of Psychedelic-Derived Novel Drugs
May 05, 2023
Tags
News
Terran Biosciences
Psychedelics
From
Benzinga
This Firm Bets On Non-Hallucinogenic Psychedelics, Files Claims For International IP Protection
April 26, 2023
Tickers
MSSTF
Tags
Guidance
News
MSSTF
From
Benzinga
Stress, Anxiety, PTSD: 2 NASDAQ-Listed Drug Developers Advance Psychedelic-Inspired Meds
April 20, 2023
Tickers
DRUG
SILO
Tags
stress levels
Psychedelic/Assisted Therapies
anxiety disorders
From
Benzinga
Are Next-Gen Psychedelics The Incoming Solution For Mental Health? Learn It All At Benzinga's Psychedelics Capital Conference
April 06, 2023
Tags
Psychedelics Financing
Biotech
Benzinga
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.